<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-14T03:26:44Z</responseDate>
  <request identifier="oai:figshare.com:article/33956511" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/33956511</identifier>
        <datestamp>2026-09-21T17:33:30Z</datestamp>
        <setSpec>category_4</setSpec>
        <setSpec>category_12</setSpec>
        <setSpec>category_13</setSpec>
        <setSpec>category_14</setSpec>
        <setSpec>category_16</setSpec>
        <setSpec>category_19</setSpec>
        <setSpec>category_21</setSpec>
        <setSpec>category_873</setSpec>
        <setSpec>category_62</setSpec>
        <setSpec>category_64</setSpec>
        <setSpec>portal_5</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>&lt;p&gt;Sequence of primers that used in the current study.&lt;/p&gt;</dc:title>
          <dc:creator>Ahmad Reza Ahmadi (25084602)</dc:creator>
          <dc:creator>Touraj Zamir Nasta (25084605)</dc:creator>
          <dc:creator>Ardeshir Abbasi (25084608)</dc:creator>
          <dc:creator>Mohammad Reza Tabandeh (9425491)</dc:creator>
          <dc:creator>Cyrus Jalili (10765342)</dc:creator>
          <dc:subject>Biochemistry</dc:subject>
          <dc:subject>Cell Biology</dc:subject>
          <dc:subject>Genetics</dc:subject>
          <dc:subject>Molecular Biology</dc:subject>
          <dc:subject>Physiology</dc:subject>
          <dc:subject>Pharmacology</dc:subject>
          <dc:subject>Biotechnology</dc:subject>
          <dc:subject>Chemical Sciences not elsewhere classified</dc:subject>
          <dc:subject>Marine Biology</dc:subject>
          <dc:subject>Cancer</dc:subject>
          <dc:subject>xlink "&gt; cyclophosphamide</dc:subject>
          <dc:subject>western blot analysis</dc:subject>
          <dc:subject>oxidative stress parameters</dc:subject>
          <dc:subject>modulating apoptotic pathways</dc:subject>
          <dc:subject>kidney injury markers</dc:subject>
          <dc:subject>bioactive saponin derived</dc:subject>
          <dc:subject>10 &amp;# 181</dc:subject>
          <dc:subject>induced renal toxicity</dc:subject>
          <dc:subject>induced renal injury</dc:subject>
          <dc:subject>time pcr assay</dc:subject>
          <dc:subject>dependent adverse effects</dc:subject>
          <dc:subject>demonstrated notable antioxidant</dc:subject>
          <dc:subject>protodioscin mitigates cyclophosphamide</dc:subject>
          <dc:subject>293 kidney cells</dc:subject>
          <dc:subject>293 cells subjected</dc:subject>
          <dc:subject>prot significantly reduced</dc:subject>
          <dc:subject>293 cells exposed</dc:subject>
          <dc:subject>prot decreased bax</dc:subject>
          <dc:subject>caspase 3 expression</dc:subject>
          <dc:subject>293 cells</dc:subject>
          <dc:subject>induced cytotoxicity</dc:subject>
          <dc:subject>reduced apoptosis</dc:subject>
          <dc:subject>protective effects</dc:subject>
          <dc:subject>mtt assay</dc:subject>
          <dc:subject>antioxidant defense</dc:subject>
          <dc:subject>cleaved caspase</dc:subject>
          <dc:subject>study aimed</dc:subject>
          <dc:subject>protein expression</dc:subject>
          <dc:subject>protective role</dc:subject>
          <dc:subject>prot exerts</dc:subject>
          <dc:subject>prot ),</dc:subject>
          <dc:subject>particularly nephrotoxicity</dc:subject>
          <dc:subject>inflammatory properties</dc:subject>
          <dc:subject>including cat</dc:subject>
          <dc:subject>ic50 concentration</dc:subject>
          <dc:subject>gene expression</dc:subject>
          <dc:subject>findings suggest</dc:subject>
          <dc:subject>established efficacy</dc:subject>
          <dc:subject>dioscoreaceae family</dc:subject>
          <dc:subject>cystatin c</dc:subject>
          <dc:subject>clinical use</dc:subject>
          <dc:subject>cell viability</dc:subject>
          <dc:subject>assessed using</dc:subject>
          <dc:subject>24 hours</dc:subject>
          <dc:description>&lt;p&gt;Sequence of primers that used in the current study.&lt;/p&gt;</dc:description>
          <dc:date>2026-09-21T17:33:18Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.1371/journal.pone.0357227.t001</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/_p_Sequence_of_primers_that_used_in_the_current_study_p_/33956511</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
